Research Reports | Market Assessment
April 2016

Sjogren’s Syndrome | Niche & Rare Disease Landscape & Forecast | US/EU5 | 2016

Sjögren’s syndrome (SS) is an autoimmune disease characterized by dry eyes, dry mouth, and often also systemic manifestations such as fatigue and joint pain. While some SS cases are secondary, co-presenting with another, primary autoimmune disease, primary SS is the most common form. Current treatment of primary SS is mostly off-label and is focused on symptomatic relief of dry eyes, dry mouth, and/or systemic manifestations. Treatments that have a proven effect on autoimmune diseases other than SS have, for the large part, not demonstrated efficacy in SS, where the greatest unmet need remains for a single therapy that, likely by targeting an underlying disease process, could simultaneously address many of the syndrome’s signs and symptoms.

Login to access report
Back to all Market Assessment reports
Login to access report

launch Related Market Assessment Reports